JOURNAL OF CLINICAL LABORATORY ANALYSIS
Scope & Guideline
Transforming research into real-world laboratory solutions.
Introduction
Aims and Scopes
- Clinical Diagnostics and Biomarkers:
The journal emphasizes research on novel biomarkers and diagnostic techniques, particularly those that enhance the accuracy and efficiency of disease detection and monitoring. - Molecular Diagnostics and Genomics:
There is a significant focus on molecular methods, including next-generation sequencing and PCR techniques, for the diagnosis of various genetic and infectious diseases. - Laboratory Methodologies and Quality Control:
The journal includes studies evaluating and optimizing laboratory methodologies, emphasizing the importance of quality control in clinical laboratories. - Therapeutic Monitoring and Drug Response:
Research related to the monitoring of therapeutic drug levels and responses in various patient populations is a key area, particularly in chronic diseases and cancer. - Infectious Disease Diagnostics:
Given the ongoing global health challenges, the journal frequently publishes articles related to the rapid diagnosis and management of infectious diseases, including COVID-19. - Clinical Applications of Artificial Intelligence:
Emerging trends in the application of artificial intelligence and machine learning in laboratory diagnostics are increasingly highlighted, showcasing innovative approaches to enhance clinical decision-making.
Trending and Emerging
- Integration of Artificial Intelligence in Diagnostics:
There is a marked increase in research focusing on the application of artificial intelligence and machine learning to improve diagnostic accuracy and efficiency in laboratory settings. - Liquid Biopsy and Circulating Biomarkers:
The trend towards utilizing liquid biopsies and circulating biomarkers for cancer diagnosis and monitoring is gaining momentum, highlighting the shift towards less invasive diagnostic methods. - Point-of-Care Testing Innovations:
Emerging technologies for point-of-care testing are increasingly featured, emphasizing the need for rapid and accessible diagnostic solutions in various clinical settings. - Microbiome Research:
Studies exploring the role of the microbiome in health and disease are on the rise, indicating a growing interest in understanding the complex interactions between microbiota and clinical outcomes. - Personalized Medicine and Pharmacogenomics:
There is an increasing focus on the role of pharmacogenomics in personalized medicine, with research aimed at tailoring treatments based on individual genetic profiles. - COVID-19 Related Research:
The impact of the COVID-19 pandemic is reflected in a surge of studies related to diagnostics, treatment monitoring, and understanding the long-term effects of the virus, showcasing the journal's responsiveness to global health challenges.
Declining or Waning
- Traditional Biochemical Assays:
There has been a noticeable decline in studies solely focused on traditional biochemical assays, as newer technologies and methodologies gain traction in laboratory diagnostics. - Basic Hematology Studies:
Research centered on fundamental hematological parameters seems to be less frequent, possibly due to the development of more sophisticated diagnostic tools and techniques. - Single-Center Studies:
The prevalence of studies conducted in single-center settings appears to be decreasing, with a growing emphasis on multicenter collaborations and large-scale studies to enhance generalizability. - Histopathology-Based Diagnoses:
The journal has seen a decline in articles focused purely on histopathological methods, as molecular and genetic approaches become more dominant in diagnostic pathology. - Non-Clinical Laboratory Studies:
There is a waning interest in studies that do not directly relate to clinical applications or laboratory practices, as the journal increasingly prioritizes research with direct clinical implications.
Similar Journals
JOURNAL OF CLINICAL PATHOLOGY
Elevating Standards in Diagnostic ExcellenceJOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.
LABORATORY MEDICINE
Fostering excellence in laboratory diagnostics and research.LABORATORY MEDICINE, published by Oxford University Press, is a pivotal journal in the fields of biochemistry and clinical biochemistry, officially indexed under ISSN 0007-5027 and E-ISSN 1943-7730. Since its inception in 1973, it has provided a vital platform for the dissemination of high-quality research, facilitating scholarly communication and innovation in laboratory diagnostics and biochemistry practices. The journal is classified in the Q3 quartile for medical biochemistry and Q4 for clinical biochemistry, reflecting its commitment to enhancing the scientific community's understanding of laboratory science. With its quarterly publications and rigorous peer-review process, LABORATORY MEDICINE serves as an essential resource for researchers, professionals, and students alike, offering insights into the latest developments and methodologies in the field. As a part of a rapidly evolving discipline, the journal is not only dedicated to publishing original research but also aims to present reviews, case studies, and expert opinions that contribute to the advancement of laboratory medicine. In a global context, it emerges as a significant player, prioritizing accessibility, though currently maintaining a subscription-based model, facilitating informed research and clinical application.
Breast Cancer-Basic and Clinical Research
Fostering collaboration for impactful research.Breast Cancer-Basic and Clinical Research is a premier open access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of breast cancer through a comprehensive approach that integrates basic and clinical research findings. Since its inception in 2008, this journal has aimed to serve as a vital platform for researchers, healthcare professionals, and students in the fields of oncology and cancer research, providing them with timely access to significant new research, clinical trials, and innovative methodologies. With its current rankings placing it in the Q3 quartile for Cancer Research and Oncology, it reflects a steady commitment to quality and relevance, ranking #167/404 in Medicine - Oncology and #133/230 in Biochemistry, Genetics and Molecular Biology - Cancer Research as of 2023. The journal is designed to foster dialogue and collaboration across disciplines, enabling advancements in therapeutic strategies and patient care. Researchers and professionals will find it an invaluable resource as it continues to push the frontiers of knowledge in breast cancer research.
ANNALS OF CLINICAL BIOCHEMISTRY
Advancing the Frontiers of Clinical Biochemistry.The Annals of Clinical Biochemistry, published by SAGE Publications Inc, is a prestigious journal that has been pivotal in advancing the field of clinical biochemistry since its inception. With an ISSN of 0004-5632 and an E-ISSN of 1758-1001, this journal provides a platform for high-quality, peer-reviewed research articles, reviews, and case studies that cover a wide range of topics, including biochemical analysis, diagnostic methodologies, and the latest advancements in clinical practices. As a recognized leader in the field, it holds a Q2 ranking in both Clinical Biochemistry and Miscellaneous Medicine categories, showcasing its contribution to the evolving landscape of medical science. The journal’s impact is further underscored by its strategic emphasis on fostering collaboration between researchers and healthcare professionals. Although it does not provide Open Access options, the accessible subscription model ensures that vital research remains within reach of academic and clinical institutions. The Annals of Clinical Biochemistry aims to promote the understanding and application of biochemical techniques in clinical settings, ensuring it remains an essential resource for researchers, professionals, and students alike.
ANNALES DE BIOLOGIE CLINIQUE
Elevating Clinical Understanding through Original ResearchANNALES DE BIOLOGIE CLINIQUE is a prominent French journal dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Immunology, and Microbiology. Published by JOHN LIBBEY EUROTEXT LTD, this journal has been a pivotal resource since its inception in 1945, offering a rich archive of original research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and clinical applications. Despite its ranking in the Q4 quartile within several scientific categories according to the 2023 Scopus rankings—positioning it at #395/636 in General Medicine and #198/221 in General Biochemistry—ANNALES DE BIOLOGIE CLINIQUE serves as a vital platform for emerging researchers and seasoned professionals alike, fostering collaboration and innovation in these vital areas of health science. As an essential tool for researchers and scholars, the journal does not currently provide open access; however, it continuously strives to enhance its impact and visibility in the scientific community through rigorous peer-reviewed content and educational contributions.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Empowering Researchers with Cutting-Edge ReviewsEXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.
Clinical Laboratory
Advancing the Frontiers of Clinical ScienceClinical Laboratory is a reputable journal dedicated to the interdisciplinary field of clinical biochemistry, genetics, and molecular biology. Published by CLIN LAB PUBL in Germany, this journal provides a platform for the dissemination of original research, reviews, and key insights into laboratory practices and innovations that play a crucial role in modern medicine and diagnostics. With an ISSN of 1433-6510 and a consistent publication history since its inception in 1964 and converging through 2024, it is indexed within the Scopus database, ranking in the 30th percentile among its peers. Although classified in the third quartile for 2023 in the field, Clinical Laboratory continues to contribute valuable knowledge and fosters collaboration among researchers, professionals, and students. Notably, it does not currently operate as an Open Access journal, which emphasizes its commitment to maintaining high-quality peer-reviewed content accessible through institutional and library subscriptions. For those in the domain, Clinical Laboratory serves as a vital resource for the latest advancements and trends shaping the future of clinical laboratory science.
Practical Laboratory Medicine
Empowering Professionals with Open Access InsightsPractical Laboratory Medicine is a distinguished peer-reviewed journal published by Elsevier, focusing on the essential advances in the fields of clinical biochemistry and radiological technology. Begun in 2015, this Open Access journal fosters an environment of scholarly communication, ensuring that valuable research is freely available to a global audience. With a current impact factor placing it in the Q3 quartile in both clinical biochemistry and radiological and ultrasound technology, the journal serves as a vital platform for researchers and professionals to disseminate innovative findings and foster interdisciplinary collaboration. The journal’s commitment to covering a broad spectrum of laboratory medicine topics, from clinical practice improvements to technological developments, underlines its importance in enhancing laboratory standards and patient care. Based in Amsterdam, Netherlands, Practical Laboratory Medicine not only contributes to the academic community but also influences practical applications in healthcare settings.
Indian Journal of Hematology and Blood Transfusion
Advancing Hematology: Unveiling Insights for Better Blood HealthIndian Journal of Hematology and Blood Transfusion, published by SPRINGER INDIA, serves as a leading platform for disseminating original research, reviews, and case studies in the field of hematology. With an ISSN of 0971-4502 and E-ISSN 0974-0449, this journal has been instrumental in advancing knowledge from 2000 to 2024, providing insights into critical issues surrounding blood disorders and transfusion practices. Currently ranked in the Q3 category for Hematology for 2023, it reflects a commitment to high-quality scientific content amidst a competitive landscape where it ranks 97/137 in Scopus for Medicine - Hematology, placing it in the 29th percentile of its peers. The journal primarily addresses a diverse readership, including researchers, healthcare professionals, and students, aiming to foster innovation and collaboration within the field. Although it operates under a subscription model, access options for individual articles and institutional subscriptions ensure that valuable research is disseminated widely to enhance medical practice and education in hematology.
International Journal of Laboratory Hematology
Connecting research and practice for the future of laboratory hematology.The International Journal of Laboratory Hematology, published by WILEY, serves as a vital resource in the field of hematology, delivering high-quality research findings and innovations within laboratory practices since its inception in 2007. This journal, accessible under Open Access options, showcases cutting-edge studies that span critical aspects of biochemistry and clinical laboratory methodologies. With a notable impact factor reflected in its Q2 and Q3 rankings across various categories—such as Biochemistry (medical) and Hematology—this journal stands out within the Scopus rankings, positioning itself within the 60th and 59th percentiles of its respective fields. Situated in the United Kingdom, the journal's objectives lie in disseminating pivotal research that enhances our understanding of hematological disorders and laboratory techniques, making it an essential tool for researchers, professionals, and students alike who are committed to advancing the science of laboratory hematology and its applications.